Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Attention Deficit Hyperactivity Disorder Market

Attention Deficit Hyperactivity Disorder Market Size

Report ID: GMI12095
Published Date: Nov 2024
Report Format: PDF

Download Free Sample

Attention Deficit Hyperactivity Disorder Market Size

The global attention deficit hyperactivity disorder market size was valued at USD 15.8 billion in 2023 and is estimated to grow at a CAGR of over 5.1% from 2024 to 2032. The growth of the industry is being driven by several critical factors, including the rising global prevalence of ADHD, advances in diagnostic technologies, and the development of innovative treatment options.

To get key market trends

Download Free Sample

For instance, according to the Centers for Disease Control and Prevention (CDC), approximately 7 million children in the U.S. aged 3 to 17 years (11.4%) have been diagnosed with ADHD, based on data from a 2022 national parent survey.

Moreover, the increase in awareness and understanding of the disorder drives the demand for improved diagnosis and treatment solutions that contribute to the market progression. Additionally, treatment options for ADHD are expanding with the introduction of both pharmacological and non-pharmacological interventions.

ADHD is a neurodevelopmental disorder that affects both children and adults, with symptoms such as inattentiveness, hyperactivity, and impulsiveness. The market encompasses the diagnosis, treatment, and management of ADHD. It includes pharmaceutical therapies, behavioral interventions, diagnostic tools, and support services aimed at improving patient outcomes in both pediatric and adult populations.

Attention Deficit Hyperactivity Disorder Market Report Attributes
Report Attribute	Details
Base Year:	2023
Attention Deficit Hyperactivity Disorder Market Size in 2023:	USD 15.8 Billion
Forecast Period:	2024 – 2032
Forecast Period 2024 – 2032 CAGR:	5.1%
2024 – 2032 Value Projection:	USD 24.6 Billion
Historical Data for:	2021 - 2023
No. of Pages:	150
Tables, Charts & Figures:	210
Segments covered:	Drug Type, Age Group, Gender, Dosage Form, Distribution Channel, and Region
Growth Drivers:	Increasing ADHD diagnosis rates Advancements in pharmaceutical treatments Increased awareness and education
Pitfalls & Challenges:	High cost of ADHD medications Side effects and concerns with medications

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global attention deficit hyperactivity disorder industry was valued at USD 15.8 billion in 2023 and is estimated to grow at a 5.1% CAGR from 2024 to 2032, driven by the rising global prevalence of ADHD and advancements in diagnostic technologies.

The stimulants segment dominated the market with USD 11.2 billion in 2023, as these medications are highly effective, with approximately 70-80% of patients responding positively.

U.S. ADHD market is expected to grow at a 5.1% CAGR, reaching USD 10.2 billion by 2032, supported by high awareness and diagnosis rates, along with a strong focus on both medication and behavioral therapy sectors.

Key players in the industry include Aytu BioPharma, Eli Lilly and Company, Ironshore, Janssen Pharmaceuticals, Lupin, Mallinckrodt, Novartis, and Pfizer.